OBJECTIVES: To summarize the current knowledge about 1) cognitive changes associated with central nervous system-directed chemotherapy and cranial radiation among children with acute lymphoblastic leukemia and brain tumors and adult survivors; and 2) interventions designed to prevent or remediate the cognitive and academic problems associated with central nervous system-directed cancer treatment. DATA SOURCES: Classic and current databased publications. CONCLUSION: Future directions for research include 1) identification of sources of variability in long-term outcomes; 2) greater understanding of the developmental evolution of deficits across the survivor lifespan; and 3) interventions to treat and prevent negative outcomes following cancer therapy. IMPLICATIONS FOR NURSING PRACTICE: Pediatric oncology nurses have a critical role in identifying children and adolescents at risk for cognitive changes associated with cancer therapy, initiating referral for assessment of cognitive changes during and after therapy, and advocating for resources to enhance cognitive and academic outcomes.
OBJECTIVES: To summarize the current knowledge about 1) cognitive changes associated with central nervous system-directed chemotherapy and cranial radiation among children with acute lymphoblastic leukemia and brain tumors and adult survivors; and 2) interventions designed to prevent or remediate the cognitive and academic problems associated with central nervous system-directed cancer treatment. DATA SOURCES: Classic and current databased publications. CONCLUSION: Future directions for research include 1) identification of sources of variability in long-term outcomes; 2) greater understanding of the developmental evolution of deficits across the survivor lifespan; and 3) interventions to treat and prevent negative outcomes following cancer therapy. IMPLICATIONS FOR NURSING PRACTICE: Pediatric oncology nurses have a critical role in identifying children and adolescents at risk for cognitive changes associated with cancer therapy, initiating referral for assessment of cognitive changes during and after therapy, and advocating for resources to enhance cognitive and academic outcomes.
Authors: Beeshman S Nandakumar; Joanna E Fardell; Claire E Wakefield; Christina Signorelli; Jordana K McLoone; Jane Skeen; Ann M Maguire; Richard J Cohn Journal: Support Care Cancer Date: 2018-03-02 Impact factor: 3.603
Authors: Mary C Hooke; Cheryl Rodgers; Olga Taylor; Kari M Koerner; Pauline Mitby; Ida Moore; Michael E Scheurer; Marilyn J Hockenberry; Wei Pan Journal: Cancer Nurs Date: 2018 Nov/Dec Impact factor: 2.592
Authors: Mary C Hooke; Daniel Hatch; Marilyn J Hockenberry; Susan Whitman; Ida Moore; David Montgomery; Kari Marano; Pauline Mitby; Michael E Scheurer; Olga Taylor; Wei Pan Journal: J Pediatr Oncol Nurs Date: 2020-03-06 Impact factor: 1.636
Authors: Ida M Ki Moore; Patricia Gundy; Alice Pasvogel; David W Montgomery; Olga A Taylor; Kari M Koerner; Kathy McCarthy; Marilyn J Hockenberry Journal: J Pediatr Hematol Oncol Date: 2015-03 Impact factor: 1.289
Authors: Ruth A Anderson; Donald E Bailey; Bei Wu; Kirsten Corazzini; Eleanor S McConnell; N Marcus Thygeson; Sharron L Docherty Journal: ANS Adv Nurs Sci Date: 2015 Apr-Jun Impact factor: 1.824